Cargando…
SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters
Chronic hepatitis B (CHB) virus infection is one of the leading causes of cirrhosis and liver cancer. Although the major drugs against CHB including nucleos(t)ide analogs and PEG-interferon can effectively control human hepatitis B virus (HBV) infection, complete cure of HBV infection is quite rare....
Autores principales: | Wu, Dai-Qing, Ding, Qiu-Ying, Tao, Na-Na, Tan, Ming, Zhang, Yuan, Li, Fan, Zhou, Yu-Jiao, Dong, Mei-Ling, Cheng, Sheng-Tao, Ren, Fang, Chen, Juan, Ren, Ji-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161175/ https://www.ncbi.nlm.nih.gov/pubmed/35663860 http://dx.doi.org/10.3389/fmicb.2022.836446 |
Ejemplares similares
-
Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022) -
ZEB2 inhibits HBV transcription and replication by targeting its core promoter
por: He, Qiao, et al.
Publicado: (2016) -
JMJD2D stabilises and cooperates with HBx protein to promote HBV transcription and replication
por: Kong, Xu, et al.
Publicado: (2023) -
KAT2A Promotes Hepatitis B Virus Transcription and Replication Through Epigenetic Regulation of cccDNA Minichromosome
por: Qin, Yi-Ping, et al.
Publicado: (2022) -
The HBV Core Protein and Core Particle Both Bind to the PPiase Par14 and Par17 to Enhance Their Stabilities and HBV Replication
por: Saeed, Umar, et al.
Publicado: (2021)